Press
All the news from Genexpath…
-
Juliette Renauld guest of the MED.Innov’ podcast
Read more : Juliette Renauld invitée du podcast MED.Innov’Cancer diagnosis, AI and regulatory issues We are delighted to share with you the intervention of Juliette Renauld, founder and CEO of Genexpath, in the first episode of the MED.Innov’ podcast, created by Marianne
-
Genexpath at the SFMPP 2024 Congress: Replay of our presentation
Read more : Genexpath au Congrès SFMPP 2024 : Replay de notre présentationFrom October 9 to 11, 2024, the Congress of the French Society of Predictive and Personalized Medicine (SFMPP) brought together researchers, clinicians and innovative companies to discuss advances in oncogenomics, genomics and artificial intelligence. As part of the
-
PODCAST: “Listen to the story of Juliette Renauld, Genexpath”
Read more : PODCAST : « Ecoutez l’histoire de Juliette Renauld, Genexpath »Listen to the story of Juliette Renauld at hitwest, Ouest France.
-
Genexpath in the United States
Read more : Genexpath aux Etats-UnisGenexpath was one of 11 companies to travel to the USA to discover the American market. Alongside regional elected officials and tourism representatives, a number of Normandy-based tech and medtech companies were present.
-
Genexpath at the SFMPP 2022 Congress: Replay of our presentation
Read more : Genexpath au Congrès SFMPP 2022 : Replay de notre présentationFrom October 5 to 7, 2022, the Congress of the French Society of Predictive and Personalized Medicine (SFMPP) brought together experts, researchers and innovative companies around the latest advances in genomics and oncogenomics. Genexpath had the opportunity to present its work as part of the session
-
10,000 startups 2022 prize: discover the winners of the Great West!
Read more : Prix 10.000 startups 2022 : découvrez les gagnants du Grand Ouest !Back for a 10th event season, the 10,000 Startups to Change the World Prize, organized by La Tribune, rewarded six startups in Nantes from the Great West, including Brittany, Normandy, Pays-de-la-Loire and Center -Val-de-Loire: Equium, Thrasos, Pennylane, Wello, Genexpath and Taxirail. Will one of them leave, in addition, with a national grand prize? Answer on March 28 on the stage of the Grand Rex in Paris.